Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INAVO123: Inavolisib + CDK4/6i + Letrozole in Advanced Breast Cancer
NCT06790693Phase 3Recruiting
- Sponsor
- Roche
- Start
- Apr 2025
- Primary completion
- Jan 2032
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of inavolisib in breast cancer, sponsored by Roche. Started Apr 2025; status: recruiting.
02
Drugs
inavolisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06790693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06790693.